Investments
454Portfolio Exits
102Funds
43Service Providers
2About Seventure Partners
Seventure Partners seeks to turn innovation into entrepreneurial ventures through the financial backing and by sharing the passion of companies they invest in. The firm actively funds companies within the two evolving fields of Digital Technologies and Life Sciences, partnering with those that have strong growth potential.
Want to inform investors similar to Seventure Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Seventure Partners
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Seventure Partners in 2 Expert Collections, including Vitamin & Supplement Startups.
Vitamin & Supplement Startups
237 items
Synthetic Biology
382 items
Latest Seventure Partners News
Jul 13, 2023
hepster, a leading European embedded insurtech, has received €10 million in a Series B financing round from existing and new investors with Element Ventures, Seventure Partners, and Claret Capital Partners (Fund III1). According to the company, the new capital consists of equity and debt. Despite a challenging fundraising environment, thanks to its continuous growth and […] The post Rostock-based insurtech hepster closes €10 million Series B to pave the way to profitability appeared first on EU-Startups.
Seventure Partners Investments
454 Investments
Seventure Partners has made 454 investments. Their latest investment was in Pitchy as part of their Series B on September 9, 2023.
Seventure Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/21/2023 | Series B | Pitchy | $42.59M | No | 1 | |
8/7/2023 | Series A | Allozymes | Yes | 2 | ||
7/10/2023 | Series B | Hepster | $11.24M | No | 10 | |
5/24/2023 | Series A | |||||
4/26/2023 | Series B |
Date | 9/21/2023 | 8/7/2023 | 7/10/2023 | 5/24/2023 | 4/26/2023 |
|---|---|---|---|---|---|
Round | Series B | Series A | Series B | Series A | Series B |
Company | Pitchy | Allozymes | Hepster | ||
Amount | $42.59M | $11.24M | |||
New? | No | Yes | No | ||
Co-Investors | |||||
Sources | 1 | 2 | 10 |
Seventure Partners Portfolio Exits
102 Portfolio Exits
Seventure Partners has 102 portfolio exits. Their latest portfolio exit was Expensya on June 08, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
6/8/2023 | Acquired | 5 | |||
6/6/2023 | Acquired | 1 | |||
4/5/2023 | Acq - Fin | Sodero Gestion, Arkea, UNEXO, and Cerea Partners | 2 | ||
Date | 6/8/2023 | 6/6/2023 | 4/5/2023 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | Acq - Fin | ||
Companies | |||||
Valuation | |||||
Acquirer | Sodero Gestion, Arkea, UNEXO, and Cerea Partners | ||||
Sources | 5 | 1 | 2 |
Seventure Partners Acquisitions
3 Acquisitions
Seventure Partners acquired 3 companies. Their latest acquisition was Easyvoyage on December 21, 2006.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
12/21/2006 | Leveraged Buyout | 1 | ||||
11/13/2002 | ||||||
10/15/2000 | Convertible Note |
Date | 12/21/2006 | 11/13/2002 | 10/15/2000 |
|---|---|---|---|
Investment Stage | Convertible Note | ||
Companies | |||
Valuation | |||
Total Funding | |||
Note | Leveraged Buyout | ||
Sources | 1 |
Seventure Partners Fund History
43 Fund Histories
Seventure Partners has 43 funds, including Health for Life Capital II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
11/4/2020 | Health for Life Capital II | 8 | |||
7/5/2019 | Sport & Performance Capital | 2 | |||
7/5/2019 | Sport & Performance Capital Fund | Multi-Stage Venture Capital | Open | 1 | |
3/20/2018 | AVF | ||||
12/14/2015 | Health for Life Capital |
Closing Date | 11/4/2020 | 7/5/2019 | 7/5/2019 | 3/20/2018 | 12/14/2015 |
|---|---|---|---|---|---|
Fund | Health for Life Capital II | Sport & Performance Capital | Sport & Performance Capital Fund | AVF | Health for Life Capital |
Fund Type | Multi-Stage Venture Capital | ||||
Status | Open | ||||
Amount | |||||
Sources | 8 | 2 | 1 |
Seventure Partners Service Providers
2 Service Providers
Seventure Partners has 2 service provider relationships
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Commercial Bank | General Business Banking | ||
Service Provider | ||
|---|---|---|
Associated Rounds | ||
Provider Type | Commercial Bank | |
Service Type | General Business Banking |
Partnership data by VentureSource
Seventure Partners Team
10 Team Members
Seventure Partners has 10 team members, including current Chief Executive Officer, Managing Partner, Isabelle de Cremoux.
Name | Work History | Title | Status |
|---|---|---|---|
Isabelle de Cremoux | Government of France, Pfizer, Ernst & Young, and Arthur Andersen | Chief Executive Officer, Managing Partner | Current |
Name | Isabelle de Cremoux | ||||
|---|---|---|---|---|---|
Work History | Government of France, Pfizer, Ernst & Young, and Arthur Andersen | ||||
Title | Chief Executive Officer, Managing Partner | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
